Combination Products

FAQ drug-medical device combination product general

GENERAL

1. What are examples of drug-medical device combination product?

Examples of drug-medical device combination products, of which the drug categories are New Drug Products, Biologics and Generics are as follows:

- Prefilled drug delivery systems (syringe without needle for oral use*, syringe for injection, insulin injector pen, metered dose inhaler)

- Drug packed with measuring spoon/ cup*,

- Drug packed with dropper*, of which it is not a part of the container / packaging

- Continuous Ambulatory Peritoneal Dialysis (CAPD) products with CAPD system (e.g. dialysate bag, drainage bag, transfer tubing, linking connector, disc, injection port, over pouch, etc.)

Note: * - All Class A ancillary medical devices do not require endorsement letter from the Medical Device Authority (MDA) for the purpose of registration of Drug-Medical Device Combination Products

Examples below are not considered as drug-medical device combination product:

- Drug packed with dropper for internal / external use; of which it is a part of the container / packaging

- Eye / ear / nose drops (multiple or single use packing)

- Drug packed with applicator for skin / external body orifice (nostril, mouth, ear canal, anus and vaginal) without dosing control.

- Nasal spray with / without dosing control

- Convenience pack products (example: first aid kit consist of medical device and non-scheduled poison products) 

2. Are the requirements in the Guideline for Registration of Drug-Medical Device and Medical Device-Drug Combination Products applicable to Natural products and Health Supplement products?

No. The guideline is not applicable to Natural products and Health Supplement products. Kindly refer to Drug Registration Guidance Document for the definition of Natural products and Health Supplement products.

3. What is the risk classification of ancillary medical device component?

Kindly refer to Guidance on the Rules of Classification for General Medical Devices available at https://portal.mda.gov.my/

4. Can NPRA reject the Endorsement letter (inclusive of acknowledgement receipt) application?

The application may be rejected if the applicant fails to respond to the NPRA within six months of the initial correspondence date or fails to fulfil the requirement after 3 correspondences. Applicants are required to submit a new application for evaluation purposes